PILMAN » questions http://www.tapanray.in A Tapan Ray Website Sun, 22 Mar 2026 10:59:18 +0000 en-US hourly 1 http://wordpress.org/?v=3.4.2 Covid 19: Some Unanswered Questions in India http://www.tapanray.in/covid-19-some-unanswered-questions-in-india/?utm_source=rss&utm_medium=rss&utm_campaign=covid-19-some-unanswered-questions-in-india http://www.tapanray.in/covid-19-some-unanswered-questions-in-india/#comments Mon, 20 Apr 2020 00:00:30 +0000 Tapan Ray http://www.tapanray.in/?p=10025 Continue reading →]]> http://www.tapanray.in/covid-19-some-unanswered-questions-in-india/feed/ 0 Multifaceted Coronavirus Narrative Raises Multiple Questions http://www.tapanray.in/multifaceted-coronavirus-narrative-raises-multiple-questions/?utm_source=rss&utm_medium=rss&utm_campaign=multifaceted-coronavirus-narrative-raises-multiple-questions http://www.tapanray.in/multifaceted-coronavirus-narrative-raises-multiple-questions/#comments Mon, 06 Apr 2020 00:00:07 +0000 Tapan Ray http://www.tapanray.in/?p=9960 Continue reading →]]> http://www.tapanray.in/multifaceted-coronavirus-narrative-raises-multiple-questions/feed/ 0 Pharma ‘Chatbots’: For Better Stakeholder Engagement http://www.tapanray.in/pharma-chatbots-for-better-stakeholder-engagement/?utm_source=rss&utm_medium=rss&utm_campaign=pharma-chatbots-for-better-stakeholder-engagement http://www.tapanray.in/pharma-chatbots-for-better-stakeholder-engagement/#comments Mon, 29 Jul 2019 00:00:01 +0000 Tapan Ray http://www.tapanray.in/?p=9647 Continue reading →]]> http://www.tapanray.in/pharma-chatbots-for-better-stakeholder-engagement/feed/ 0 Grant of Compulsory License for Bayer’s Nexavar in India raises more questions than answers http://www.tapanray.in/grant-of-compulsory-license-for-bayers-nexavar-in-india-raises-more-questions-than-answers/?utm_source=rss&utm_medium=rss&utm_campaign=grant-of-compulsory-license-for-bayers-nexavar-in-india-raises-more-questions-than-answers http://www.tapanray.in/grant-of-compulsory-license-for-bayers-nexavar-in-india-raises-more-questions-than-answers/#comments Mon, 26 Mar 2012 00:00:05 +0000 Tapan Ray http://tapanray.in/index.php/?p=116 Continue reading →]]> http://www.tapanray.in/grant-of-compulsory-license-for-bayers-nexavar-in-india-raises-more-questions-than-answers/feed/ 0 Challenges for the Pharmaceutical Industry in the new paradigm – there are more questions than answers http://www.tapanray.in/challenges-for-the-pharmaceutical-industry-in-the-new-paradigm-there-are-more-questions-than-answers/?utm_source=rss&utm_medium=rss&utm_campaign=challenges-for-the-pharmaceutical-industry-in-the-new-paradigm-there-are-more-questions-than-answers http://www.tapanray.in/challenges-for-the-pharmaceutical-industry-in-the-new-paradigm-there-are-more-questions-than-answers/#comments Mon, 19 Apr 2010 01:00:54 +0000 Tapan Ray http://tapanray.in/index.php/?p=439 Continue reading →]]> http://www.tapanray.in/challenges-for-the-pharmaceutical-industry-in-the-new-paradigm-there-are-more-questions-than-answers/feed/ 0